As genomic technologies move from treating disease to selecting future individuals, definitions of disease cease to function exclusively as medical categories and become social decisions about which traits and what kinds of people should exist.
The ability to reduce the burden of genetic disease is one of the most compelling promises of genomic medicine. But the path forward for embryo selection and gene editing is not purely technical; it demands rigorous evaluation of scientific evidence, sustained ethical reflection, and broad public consensus.